This site is intended for health professionals only!

Published on 1 January 2007

Share this story:
Twitter
LinkedIn
Share
RELATED ARTICLES
Genmab announces Phase II study of Daratumumab in smouldering multiple myeloma
Tamiflu stock “to cover 25% of UK”
Journal attacks “populist” anti-HAI initiatives
Recent advances in atopic dermatitis treatment
Mesalazine approved for ulcerative colitis

Once-daily combination therapies in HIV patients

teaser

Esteban Ribera
MD PhD
Head of HIV Infection
Infectious Diseases Division
Hospital Universitario Vall d’Hebr



Most read

1
Feedback: Automation systems in your hospital
2
Helapet introduce new, improved 20mm Vented Vial Adapter
3
Janssen-Cilag’s Stelara approved by NICE
4
Merck agrees huge Vioxx settlement
5
User-friendly osteoporosis therapy launched



Latest Issue

Read the latest issue >
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:
Twitter
LinkedIn
Share
RELATED ARTICLES
Biogen Idec and Sobi announce positive top-line results
Takeda announces 4-year survival data from ADCETRIS® pivotal trial at ASH annual meeting
Antidepressants may reduce epilepsy sudden death
Shire to withdraw ProAmatine
Positive data for azacitidine in MDS